Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 18 and 80 years old
- People who have been diagnosed with a type of lung cancer called non-small cell lung cancer (NSCLC) that has a specific gene change known as an EGFR mutation, confirmed by lab testing
- People who have received a type of targeted drug treatment before surgery (called neoadjuvant targeted therapy)
- People who are scheduled to have surgery intended to remove the cancer
Who may not be able to join:
- People who have previously received chemotherapy, immunotherapy, or radiation therapy
- People who have a history of another cancer, or who have previously had lung surgery
- People whose medical records are missing important information needed for the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Guibin Qiao, Guangdong Provincial People's Hospital
Phone: +86-13602749153
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease-free survival (DFS); Event-free survival (EFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.